Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-27 4:26 pm Purchase | 13G | JASPER THERAPEUTICS INC NE JSPR | Avidity Partners Management LP | 760,000 5.1% | 760,000 (New Position) | View |
2024-02-14 10:33 am Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Avidity Partners Management LP | 11,188,743 9.5% | -192,330 (-1.69%) | View |
2024-02-14 06:50 am Sale | 13G | KEZAR LIFE SCIENCES INC KZR | Avidity Partners Management LP | 5,025,454 6.9% | -1,756,946 (-25.90%) | View |
2024-02-14 06:44 am Sale | 13G | IDEAYA BIOSCIENCES INC IDYA | Avidity Partners Management LP | 1,520,000 2.4% | -2,304,800 (-60.26%) | View |
2024-02-14 06:37 am Sale | 13G | ALTIMMUNE INC ALT | Avidity Partners Management LP | 0 0% | -3,990,000 (Position Closed) | View |
2024-02-13 9:44 pm Sale | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Avidity Partners Management LP | 3,950,000 4.7% | -2,768,142 (-41.20%) | View |
2024-02-13 9:40 pm Sale | 13G | AKERO THERAPEUTICS INC AKRO | Avidity Partners Management LP | 235,000 0.4% | -3,590,000 (-93.86%) | View |
2024-02-13 9:34 pm Sale | 13G | FUSION PHARMACEUTICALS INC FUSN | Avidity Partners Management LP | 6,500,328 8.1% | -324,122 (-4.75%) | View |
2024-02-13 9:18 pm Sale | 13G | NANOSTRING TECHNOLOGIES INC CO NSTG | Avidity Partners Management LP | 0 0% | -2,950,000 (Position Closed) | View |
2024-02-13 8:41 pm Purchase | 13G | SCYNEXIS INC SCYX | Avidity Partners Management LP | 4,105,210 9.9% | 480,687 (+13.26%) | View |
2024-02-13 8:22 pm Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | Avidity Partners Management LP | 2,662,206 9.9% | 472,487 (+21.58%) | View |
2024-02-13 8:14 pm Unchanged | 13G | ARVINAS INC ARVN | Avidity Partners Management LP | 2,985,117 4.4% | 0 (Unchanged) | View |
2024-02-13 7:49 pm Sale | 13G | PROTHENA CORP PLC SHS PRTA | Avidity Partners Management LP | 0 0% | -2,953,000 (Position Closed) | View |
2024-02-13 7:43 pm Sale | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | Avidity Partners Management LP | 0 0% | -5,150,000 (Position Closed) | View |
2024-02-13 7:18 pm Sale | 13G | ARVINAS INC ARVN | Avidity Partners Management LP | 2,985,117 4.4% | -1,964,883 (-39.69%) | View |
2024-02-13 7:14 pm Sale | 13G | CYTEIR THERAPEUTICS INC CYT | Avidity Partners Management LP | 0 0% | -1,795,800 (Position Closed) | View |
2024-02-13 7:08 pm Sale | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Avidity Partners Management LP | 0 0% | -4,100,000 (Position Closed) | View |
2024-01-31 12:11 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Avidity Partners Management LP | 2,922,823 9.9% | 2,922,823 (New Position) | View |
2024-01-16 4:12 pm Purchase | 13G | IMMUNIC INC IMUX | Avidity Partners Management LP | 8,899,418 9.9% | 8,899,418 (New Position) | View |
2024-01-08 4:18 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | Avidity Partners Management LP | 6,360,212 7.2% | 6,360,212 (New Position) | View |